26.05.2024, 706 Zeichen

Valneva: Valneva, a specialty vaccine company, today announced the appointment of Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer (CSO) and Executive Committee member, effective June 3, 2024. Dr. Schuitemaker brings more than two decades of experience in vaccine discovery and development. She formerly served as Global Head of Viral Vaccine Discovery and Translational Medicine at Johnson & Johnson (J&J), with responsibility for the strategy and execution of vaccine programs on COVID-19, HIV, RSV, Ebola, and multiple other viral disease targets for almost 14 years.
Valneva: weekly performance: -5.37%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (20/05/2024)

Christian Drastil: Wiener Börse Plausch

Alsercast #11: Der neue Althanquartier-Eigentümer im sehr persönlichen Talk zum Status Quo hier vor Ort, man ist voller Zuversicht

Bildnachweis

Aktien auf dem Radar:Amag, EuroTeleSites AG, Warimpex, Pierer Mobility, AT&S, Austriacard Holdings AG, Rosgix, Immofinanz, Uniqa, SBO, Bawag, Mayr-Melnhof, DO&CO, Österreichische Post, Kapsch TrafficCom, UBM, Palfinger, SW Umwelttechnik, Oberbank AG Stamm, Flughafen Wien, Marinomed Biotech, Addiko Bank, Agrana, EVN, OMV, Telekom Austria, VIG, adidas, Siemens Energy.

---